Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    ORIC Pharmaceuticals Inc.

    NASDAQ: ORIC · Real-Time Price · USD
    9.43
    -0.20 (-2.08%)
    At close: Jun 16, 2025, 3:59 PM
    9.25
    -1.95%
    After-hours: Jun 16, 2025, 07:32 PM EDT

    ORIC Pharmaceuticals Statistics

    Share Statistics

    ORIC Pharmaceuticals has 85.22M shares outstanding. The number of shares has increased by 5.35% in one year.

    Shares Outstanding

    n/a
    		 85.22M

    Shares Change (YoY)

    n/a
    		 5.35%

    Shares Change (QoQ)

    n/a
    		 0.65%

    Owned by Institutions (%)

    n/a
    		 99.99%

    Shares Floating

    n/a
    		 47.89M

    Failed to Deliver (FTD) Shares

    n/a
    		 4,473

    FTD / Avg. Volume

    n/a
    		 0.38%

    Short Selling Information

    The latest short interest is 13.35M, so 18.78% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 13.35M

    Short % of Shares Out

    n/a
    		 18.78%

    Short % of Float

    n/a
    		 19.11%

    Short Ratio (days to cover)

    n/a
    		 5.1

    Valuation Ratios

    The PE ratio is -4.4 and the forward PE ratio is -5.57. ORIC Pharmaceuticals's PEG ratio is 0.66.

    PE Ratio

    n/a
    		 -4.4

    Forward PE

    n/a
    		 -5.57

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 9.6

    PB Ratio

    n/a
    		 2.31

    P/FCF Ratio

    n/a
    		 -4.94

    PEG Ratio

    n/a
    		 0.66
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for ORIC Pharmaceuticals.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 10.56, with a Debt / Equity ratio of 0.01.

    Current Ratio

    n/a
    		 10.56

    Quick Ratio

    n/a
    		 10.56

    Debt / Equity

    n/a
    		 0.01

    Debt / EBITDA

    n/a
    		 -0.03

    Debt / FCF

    n/a
    		 -0.03

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,047,926.23

    Employee Count

    n/a
    		 122

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by 26.75% in the last 52 weeks. The beta is 1.48, so ORIC Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.48

    52-Week Price Change

    n/a
    		 26.75%

    50-Day Moving Average

    n/a
    		 6.21

    200-Day Moving Average

    n/a
    		 8.36

    Relative Strength Index (RSI)

    n/a
    		 69.52

    Average Volume (20 Days)

    n/a
    		 1,170,257

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -142.9M

    Net Income

    n/a
    		 -127.85M

    EBITDA

    n/a
    		 -126.74M

    EBIT

    n/a
    		 n/a

    Earnings Per Share (EPS)

    n/a
    		 -1.83
    Full Income Statement

    Balance Sheet

    The company has 59.41M in cash and 3.18M in debt, giving a net cash position of 56.22M.

    Cash & Cash Equivalents

    n/a
    		 59.41M

    Total Debt

    n/a
    		 3.18M

    Net Cash

    n/a
    		 56.22M

    Retained Earnings

    n/a
    		 -562.77M

    Total Assets

    n/a
    		 242.86M

    Working Capital

    n/a
    		 193.82M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -112.66M and capital expenditures 0, giving a free cash flow of -113.85M.

    Operating Cash Flow

    n/a
    		 -112.66M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -113.85M

    FCF Per Share

    n/a
    		 -1.63
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    ORIC does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for ORIC is $20, which is 112.1% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $20

    Price Target Difference

    n/a
    		 112.1%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 8
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 10.25

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist